KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Non-Current Deferred Tax Liability (2020 - 2025)

Castle Biosciences' Non-Current Deferred Tax Liability history spans 5 years, with the latest figure at $3.2 million for Q3 2025.

  • For Q3 2025, Non-Current Deferred Tax Liability fell 23.18% year-over-year to $3.2 million; the TTM value through Sep 2025 reached $3.2 million, down 23.18%, while the annual FY2024 figure was $24.3 million, 11690.29% up from the prior year.
  • Non-Current Deferred Tax Liability for Q3 2025 was $3.2 million at Castle Biosciences, up from $3.1 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $24.3 million in Q4 2024 and bottomed at $206000.0 in Q4 2023.
  • The 5-year median for Non-Current Deferred Tax Liability is $614000.0 (2022), against an average of $2.7 million.
  • The largest YoY upside for Non-Current Deferred Tax Liability was 11690.29% in 2024 against a maximum downside of 53.29% in 2024.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $635000.0 in 2021, then plummeted by 32.6% to $428000.0 in 2022, then tumbled by 51.87% to $206000.0 in 2023, then soared by 11690.29% to $24.3 million in 2024, then crashed by 86.65% to $3.2 million in 2025.
  • Per Business Quant, the three most recent readings for CSTL's Non-Current Deferred Tax Liability are $3.2 million (Q3 2025), $3.1 million (Q2 2025), and $837000.0 (Q1 2025).